Deal typeCapital Markets
IndustryLife Sciences
Client nameRegal Pharmaceuticals Limited
Regal Pharmaceuticals raised £6.57 million to develop a new facility dedicated to penicillin-based products.
Regal Pharmaceuticals is a leading manufacturer of essential pharmaceutical products in Eastern and Central Africa. It seeks to expand its production capacity to increase its market share in the regional market. The company has a manufacturing plant in Kenya, with distribution centers across Uganda, Tanzania, Rwanda, Burundi, South Sudan, Zambia, and Somalia. 55% - 60% of the manufacturer’s current sales revenue is generated from exports to other Sub-Saharan African countries via their distribution network.
BDO acted as financial and debt advisor to Regal Pharmaceuticals Limited.
Regal Pharmaceuticals is a leading manufacturer of essential pharmaceutical products in Eastern and Central Africa. It seeks to expand its production capacity to increase its market share in the regional market. The company has a manufacturing plant in Kenya, with distribution centers across Uganda, Tanzania, Rwanda, Burundi, South Sudan, Zambia, and Somalia. 55% - 60% of the manufacturer’s current sales revenue is generated from exports to other Sub-Saharan African countries via their distribution network.
BDO acted as financial and debt advisor to Regal Pharmaceuticals Limited.